Search for Clinical Trial Results
Osteogenesis Imperfecta - 37 Studies Found
Status | Study |
Recruiting |
Study Name: A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804 Condition:
|
Recruiting |
Study Name: Evaluation and Intervention for the Effects of Osteogenesis Imperfecta Condition:
Date: 1999-11-03 |
Not yet recruiting |
Study Name: Pregnancy in Osteogenesis Imperfecta (OI) Registry Condition:
Date: 2017-01-25 Interventions: Other: Web-based Survey Patients will be sent an email invitation describing the study. If the participa |
Completed |
Study Name: Osteogenesis Imperfecta (OI) Quality of Life Survey Pilot Project 2 Condition:
Date: 2016-05-26 Interventions: Other: Web-based Survey This study will occur online. Participants will be asked to complete multiple su |
Recruiting |
Study Name: Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI Condition: Osteogenesis Imperfecta Date: 2015-01-28 Interventions: Drug: Denosumab All subjects will receive denosumab 1 mg/kg (up to a maximum of 60 mg) given subcutaneou |
Completed |
Study Name: Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta Condition:
|
Completed |
Study Name: An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta Condition: Osteogenesis Imperfecta Date: 2009-09-21 Interventions: Drug: Zoledronic Acid Each patient is to receive an initial dose of zoledronic acid of 0.0125 mg per kg |
Recruiting |
Study Name: A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804 Condition:
|
Completed |
Study Name: Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta Condition: Osteogenesis Imperfecta Date: 2005-08-15 Interventions: Drug: Zoledronic Acid |
Completed |
Study Name: Growth Hormone Therapy in Osteogenesis Imperfecta Condition: Osteogenesis Imperfecta Date: 1999-11-03 Interventions:
|